Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Robotic surgical systems market in China to grow at 12% CAGR through 2033, forecasts GlobalData

China is experiencing a surge in the adoption of robotic systems across various healthcare domains. As the demand for advanced medical technologies continues to escalate, robotic systems are becoming integral to surgical procedures, diagnostic processes, and patient care. Against this backdrop, the robotic surgical systems market in China is expected to grow at a compound […]
Read more

GenAI job postings surge in Q3 2023 as businesses embrace AI transformation, reveals GlobalData

As the new transformation unfolds, businesses are navigating the digital landscape, adapting, and innovating to witness the power of generative artificial intelligence (genAI), ensuing their relevance and competitiveness in this new era. As companies are swiftly developing medium and long-term talent plans to adapt to the evolving work landscape driven by genAI, there is an […]
Read more

China’s destroyer expenditure to grow at 5.2% CAGR through 2033 amid South China Sea tensions, says GlobalData

China’s sovereignty claims over territory in the South China Sea have antagonized competing claimants such as the Philippines, Malaysia, Indonesia, Brunei, Vietnam, and Taiwan. In addition, the US’ involvement in favor of some of these countries compelled China to build advanced combat capabilities to counter the US Navy’s aerial and naval assets. Consequently, China’s expenditure […]
Read more

Next-generation sequencing breakthroughs drive personalized medicine into mainstream healthcare, says GlobalData

The landscape of next-generation sequencing (NGS) is undergoing a transformative shift, with the cost of sequencing plummeting to less than $100 per genome. This drastic reduction, fueled by intense competition and technological advancements, has propelled the widespread adoption of personalized medicine. This evolution holds the promise of tailoring medical interventions to individual genetic profiles for […]
Read more

Sam Altman’s removal as OpenAI CEO will have significant implications for GenAI technologies, says GlobalData

As enterprises eagerly integrate generative AI (GenAI) into their operations, the market, poised to grow from $1.8 billion in 2022 to a staggering $33 billion by 2027, faces unexpected challenges. The departure of Sam Altman as CEO of OpenAI could have profound ramifications on the evolving landscape of generative artificial intelligence (AI), says GlobalData, a […]
Read more

Sugemalimab approval in China makes it only second drug approved globally for ENKTL, says GlobalData

CStone Pharmaceuticals’ sugemalimab (Cejemly) has been approved by the China National Medical Products Administration (NMPA) for the treatment of relapsed or refractory extranodal natural killer/T-cell lymphoma (r/r ENKTL) in October 2023. With this approval, sugemalimab becomes the first anti-PD-1/PD-L1 monoclonal antibody approved for r/r ENKTL globally and is expected to boost CStone’s presence in the […]
Read more

Apple embraces RCS amid EU regulatory pressure, observes GlobalData

Following Apple’s decision to adopt rich communication services (RCS) in place of SMS and MMS messaging; Ardit Ballhysa, Technology Analyst at GlobalData, a leading data and analytics company, offers his view: “No longer will Tim Cook’s words to ‘buy your mom an iPhone’ echo in the dreams of interoperability purists. To be clear, iMessage will […]
Read more

Social media giants face privacy challenges and rise of decentralized apps, says GlobalData

The landscape of social media is undergoing a transformation as Big Tech faces challenges from privacy regulations and heightened user concerns. The industry’s future rests on navigating evolving user preferences and regulatory pressures, striking a delicate balance between personalized advertising, user data privacy, and innovation, says GlobalData, a leading data and analytics company. GlobalData’s latest […]
Read more

Japan to persist with Mogami-class frigate construction amid economic turmoil, notes GlobalData

Japan has earmarked $50 billion for defense in 2023, directing substantial investments towards naval vessels and surface combatant development to bolster the nation’s self-defense forces. Despite economic challenges, the Ministry of Defense has proposed a noteworthy 17.2% increase in the 2024 defense budget. This boost is anticipated to fund the construction of two advanced Mogami-class […]
Read more

Vertex Pharmaceuticals poised for dominance in global gene therapy market with first CRISPR approval, says GlobalData

Following the news that the UK Medicines and Healthcare Products Regulatory Agency has granted conditional marketing authorization to Vertex Pharmaceuticals and CRISPR Therapeutics‘ Casgevy, marking the world’s first approval of a CRISPR-based gene editing therapy; Joselia Carlos, Medical Device Analyst at GlobalData, offers her view: “The approval of Casgevy for sickle cell anemia (SCA) and […]
Read more

Verve Therapeutics gene-edited therapy sparks influencer debates on cholesterol reduction and cardiovascular health

Verve Therapeutics’ investigational medicine, VERVE-101, has reportedly shown a remarkable 55% reduction in bad cholesterol levels during early clinical trials. The single-dose, gene-edited therapy holds immense promise for those with familial hypercholesterolemia, addressing a critical need in heart health. This has triggered a dramatic rise in discussions over the preceding week around “Gene Editing” on […]
Read more

India, China, and AI mentions up, reveals GlobalData Company Filings Analytics report

ADS, Automotive, Power, Construction, Mining, Technology, Banking & Payments, and Medical industries sentiment improved in Q3 2023 Asia Pacific, North America, and the UK were trending with better sentiment Supply Chain and Robotics among themes with high mentions and favorable sentiment Global sentiment experienced a positive shift in the third quarter (Q3) of 2023. While […]
Read more
1 … 84 85 86 87 88 … 209